Inicio › Cáncer metastásico › Indiana › Indianapolis
Ensayos clínicos de Cáncer metastásico en Indianapolis, IN
19 estudios para Cáncer metastásico buscan participantes en centros de Indianapolis y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
ReclutandoFase 1
- IU Simon Cancer Center, Indianapolis
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
ReclutandoFase 1
- Indiana University Simon Comprehensive Cancer Center, Indianapolis
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
ReclutandoFase 3
- Franciscan Health, Indianapolis
- Franciscan Health Mooresville, Mooresville · A 16 mi de distancia
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ReclutandoFase 3
- Community Health Network, Inc, Indianapolis
- Community Health Network, Inc., Indianapolis
- Community Health Network, Inc., Indianapolis
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
ReclutandoFase 3
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
- Franciscan Health, Indianapolis
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
ReclutandoFase 3
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
- Franciscan Health, Indianapolis
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
ReclutandoFase 3
- Indiana University Health University Hospital, Indianapolis
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
ReclutandoFase 1/2
- Community Health Network, Indianapolis
AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
ReclutandoFase 1
- Community Health Network MD Anderson Cancer Center - North, Indianapolis
Prospective Validation of a Points Score System Predicting 30-day Survival
ReclutandoEstudio observacional
- Methodist Hospital, Indianapolis
- IU Health West, Avon · A 13 mi de distancia
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ReclutandoFase 3
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
- Franciscan Health, Indianapolis
- Community Cancer Center North, Indianapolis
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Community Cancer Center North, Indianapolis
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
ReclutandoFase 1
- Indiana University (IU) Melvin and Bren Simon Cancer Center, Indianapolis
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Community Health Network, Indianapolis
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
ReclutandoFase 3
- Research Site, Indianapolis
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
ReclutandoFase 3
- Franciscan Health Indianapolis, Indianapolis
A Study of LY4175408 in Participants With Advanced Cancer
ReclutandoFase 1
- Community Health Network, Indianapolis
Evaluating Disparities in Precision Oncology
ReclutandoEstudio observacional
- Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
ReclutandoFase 2/3
- Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
Ensayos de Cáncer metastásico en otras ciudades
- Houston, TX104 estudios
- New York City, NY93 estudios
- Nashville, TN70 estudios
- Boston, MA63 estudios
- Los Angeles, CA57 estudios
- St. Louis, MO54 estudios
- Arlington, VA53 estudios
- Philadelphia, PA46 estudios
- Chicago, IL45 estudios
- San Antonio, TX44 estudios
- Washington, DC43 estudios
- Dallas, TX42 estudios
Otros estudios en Indianapolis
- Cáncer de pulmón de células no pequeñas32 estudios
- Cáncer (todos los tipos)24 estudios
- Fallo cardíaco23 estudios
- Obesidad20 estudios
- Cáncer de seno20 estudios
- Cáncer del colon y del recto18 estudios
- Cáncer de ovario17 estudios
- Enfermedad cardiovascular17 estudios
- Cáncer de pulmón16 estudios
- Diabetes tipo 114 estudios
- Cáncer de endometrio14 estudios
- Enfermedad de Alzheimer14 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.